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Abstract 
Synaesthesia is  an inherited condition causing unusual  secondary sensations (e.g.,  sounds
might be experienced as both auditory and visual percepts). The condition has been linked
with  cognitive  and  perceptual  benefits  and  is  considered  a  benign  alternative  form  of
perception.  Here  we  investigate  self-referred  synaesthete  populations  and  their  rates  of
radiologically determined white matter hyperintensities (WMH) of a type compatible with the
McDonald imaging criteria for the diagnosis of multiple sclerosis  (MS). MS is  a chronic
condition resulting in damage to myelination surrounding nerve fibres of the central nervous
system. Magnetic resonance imaging features highly suggestive of MS without overt clinical
symptoms are termed Radiologically Isolated Syndrome (RIS). We present data showing that
the shared MRI profile of MS and RIS has been significantly over-represented in synaesthetes
who have participated in neuroimaging research. We present validation of the clinical and
MRI status of these synaesthetes, and an analysis showing the significant probability their
unusual numbers may not have arisen by chance. We discuss how to interpret significant data
based on small case-numbers, and consider the implications of our findings for synaesthesia’s
clinical status. 
Keywords: Synaesthesia, synesthesia, multiple sclerosis, radiologically isolated syndrome ,
co-morbidity
Introduction
For people with synaesthesia, stimuli are experienced with unusual secondary associations.
For example, sound-colour synaesthetes experience sound stimuli as accompanied by both
auditory  and  visual  (i.e.,  colour)  percepts  (Asher  et  al.,  2006).  Synaesthesia  tends  to  be
regarded in positive rather than negative terms, and has a range of cognitive and perceptual
benefits (e.g., for memory; Yaro and Ward, 2007). Here, we investigate an observation of
unusually  high  rates  of  white  matter  hyperintensities  in  a  group  of  synaesthetes.  These
hyperintensities are areas of high intensity on T2-weighted MRI scans of a type compatible
with the McDonald (imaging) criteria for the diagnosis of multiple sclerosis (MS; Polman et
al., 2003). 
MS is an inflammatory disease of the central nervous system (CNS) with a broad range of
perceptual and motor symptoms. It is thought to be caused by environmental risk-factors in
2
combination with genetic susceptibility (Compston and Coles, 2008). MS is characterised by
demyelination,  axonal  loss  and  gliosis  of  white  matter  (Weiner,  2009).  Diffusion  tensor
imaging (DTI) shows reduced fractional anisotropy (FA) scores in MS patients, indicating
reduced  white  matter  integrity  in  lesion  sites  and  elsewhere  (Roosendaal  et  al.,  2009).
Although MS is typically classified as a white matter disorder, grey matter is also affected,
with reduced volume common in several areas (Ceccarelli et al., 2008). If patients present
with MRI features suggestive of MS but without overt  clinical symptoms,  this  is  termed
Radiologically Isolated Syndrome (RIS). From a radiological perspective, MRI scans of RIS
and  MS  are  indistinguishable,  and  it  is  only  the  presence  of  clinical  symptoms  that
differentiates between the two conditions. There is also a clinical relationship between the
conditions in that approximately one third of patients with RIS develop MS symptoms within
2-5 years (Granberg et al., 2013). 
Structural differences in white and grey matter also characterise the condition of synaesthesia.
Synaesthetes show both increases and decreases in grey matter volume (Jäncke et al., 2009;
Hänggi et al., 2008) and altered coherence of white matter ( Rouw and Scholte, 2007; Hänggi
et al., 2011; Jäncke et al., 2009). This altered white matter is found in regions implicated by
the synaesthetic report, and also elsewhere. For example, synaesthetes experiencing colour
sensations show increased FA compared with controls near colour selective region V4 (Rouw
and Scholte,  2007)  but  also show FA increases (Rouw and Scholte,  2007) and decreases
(Hänggi et al., 2008) in parietal lobe. The cortical reorganisation of white and grey matter in
synaesthesia  might  call  for  comparison with  MS-RIS,  and we ask  in  this  paper  whether
epidemiological or pathological links might exist between them.
Our question is motivated by a particularly high occurrence of MRI abnormalities consistent
with the neuroradiological profile of MS-RIS within synaesthetes who have presented to our
laboratories for brain imaging studies. In three independent synaesthete cohorts across three
countries (San Diego, USA; Paris, France; Edinburgh, UK) we have opportunistically found
clinical  and/or  radiological  indicators  suggestive  of  MS in  1  in  6  synaesthetes,  1  in  10
synaesthetes and 1 in 13 synaesthetes, respectively. Our studies were not initiated with the
intention of investigating the prevalence of MS-RIS, but our unexpected findings have led us
to evaluate the post-hoc detection of white matter abnormalities in these three participants.
All three affected cases met the McDonald (imaging) criteria for the diagnosis of MS. Subject
1 (USA) has a full diagnosis of MS, while Subjects 2 (France) and 3 (UK) are currently free
from clinical symptoms and therefore considered to have RIS. Subjects 2 and 3 were initially
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flagged by routine protocols in our studies in which neuroradiologists examine T2-weighted
axial MRI scans for unanticipated pathology. Subject 1’s diagnosis was first suggested by her
GP several months after our study, because routine radiological checks were not part of that
study’s protocol.
Our finding of three cases of MS-RIS among 29 synaesthetes is suggestive of an unusually
high rate. However, we must address the possibility that we have inadvertently focussed on
just those studies where anomalies were found, rather than all synaesthesia imaging studies to
date.  Collectively,  29  published  studies  (see  table  2)  have  scanned  211  synaesthetes
(including 6 of our own 29 synaesthetes, described in Hubbard et al., 2005). Together with
our remaining unpublished cases (n=23), this gives 234 synaesthete scans in existence known
to us. Outside our cohort of 29 participants, we have been able to ascertain that 80 additional
synaesthetes’ MRI scans were checked with a similar radiologist protocol, and none revealed
anomalous findings of this type1. A further 121 were scanned without this protocol and the
remaining four scans have an unknown status. The most conservative approach is to assume
no cases of pathology in any of the 234 scanned cases, other than the three identified here.
Our methodology below is to evaluate this occurrence of MS-RIS in synaesthetes against
appropriate  baselines.  We  first  begin  with  full  case  descriptions  of  the  three  affected
synaesthetes. This is followed by a set of analyses which consider the appropriate baselines
against which to compare our finding of 3 affected cases (1 MS; 2 RIS). To anticipate our
methodologies below, we take the most stringent standards against which to compare our
observations  (given  factors  such  as  the  geographic  variability  of  MS,  and  the  sampling
method of our studies) and nonetheless find that the number of affected cases is significantly
higher than chance would predict.
Empirical Study
In this section we evaluate our three cases of MS-RIS both qualitatively and quantitatively,
beginning with a detailed clinical evaluation.
Case-details of affected synaesthetes
1 Where MS-RIS anomalies were found, authorship was invited for the current paper and this would 
explain why 3 cases were found in our own cohort but not elsewhere.
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Synaesthesia Status: Table 1 shows the synaesthetic status and demographic background of
the three synaesthete participants in whom radiological anomalies have been identified. The
table shows their  synaesthesia  phenotypes,  and these comprise  the  following:  grapheme-
colour synaesthesia gives rise to coloured percepts triggered by letters and/or digits (e.g., the
letter  A might be red; Asher et al.,  2006);  sequence-personality synaesthesia gives rise to
complex personifications triggered by the members of linguistic sequences (e.g.,  Monday
might  be  “female,  unfriendly”;  Simner  & Holenstein,  2007);  number-space  synaesthesia,
letter-space synaesthesia and time-space synaesthesia are all variants of the broader category
of sequence-space synaesthesia, in which linguistic sequences are perceived in spatial arrays
(e.g., the letters A-Z might extend in an undulating line from right-to-left across the visual
field; see Simner, 2009 for review).
Table 1. Synaesthetic Case Descriptions. For each affected synaesthete, the table shows the
imaging lab testing site, the participant’s age at  scanning, sex, country of origin, verified
synaesthesia phenotype(s), and the clinical status.
Test Site Age Sex Nationalit
y
Synaesthesia Phenotype(s)* MS-RIS?
San Diego 26 female American grapheme-colour MS
Paris 25 female French number-space, time-space 
(coloured), grapheme-
colour
RIS
Edinburgh 31 female British
/English
sequence-personality, letter-
space, numbers-space, time-
space
RIS
*Verification of synaesthesia relies on the behavioural ‘gold standard’ test for synaesthesia, which assesses the
consistency of  the synaesthetic  report  over time (e.g.,  Simner et  al.,  2006; Eagleman et  al.,  2007).  In  this,
participants are required to first report their synaesthetic experiences for a list of provided stimuli (e.g., they
report their colours for a list of letters), and they are subsequently retested after some considerable time (e.g., 6
months, for the case scanned in San Diego; see Hubbard et al., 2006 for methodological details). Synaesthetes
are identified as those who are significantly more consistent in their reports over time, compared to a group of
matched controls who invent/recall analogous associations.
Clinical status of MS-RIS: All three synaesthete participants in question met the McDonald
(imaging) criteria for the diagnosis of multiple sclerosis. This requires the presence of one or
more T2 weighted high signal lesions in at least two of the following four areas of the CNS:
periventricular, juxtacortical, infratentorial or spinal cord. A full diagnosis of MS has been
given in the case of one participant,  while the other two subjects are currently free from
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clinical symptoms and are therefore considered to have RIS. The synaesthetic status of each
participant is shown in Table 1 above and their clinical status is described here. 
Subject 1 (San Diego, USA) was diagnosed with clinically definite relapsing-remitting MS
several months after taking part in a synaesthesia study in 2001. A diagnosis of MS was first
suggested by this participant's GP because routine radiological checks were not part of that
study’s  protocol.  Subsequent  neurological  follow-up  consisting  of  sagittal  and  axial  T1
FLAIR,  axial  T2  and  axial  and  coronal  T1  weighted  MRI  scans  revealed  extensive
hyperintensities in both the brain and cervical spine, considered to be pathognomonic for MS.
These white matter lesions, in conjunction with history of clinical symptoms, confirmed this
participant's  diagnosis  of  MS.  This  participant  had  a  total  of  16  lesions,  in  both
periventricular  and juxtacortical  white  matter  (see Figure 1).  Periventricular  lesions  were
located in the corpus callosum and in occipital and parietal areas. Juxtacortical lesions were
found in the parietal region. Lesions were also detected in the spinal cord. This subject was
originally scanned for, but subsequently excluded from, Hubbard et al., 2005 (see Table 2). 
Subject 2 (Paris, France) participated in synaesthesia research in 2006, where her axial T2
MRI scan was reviewed as  part  of routine assessments  for  unanticipated pathology by a
consultant  neuroradiologist.  Initial  examination  of  her  resultant  T2-weighted  MRI  scan
revealed white matter hyperintensities in the brain. A second, axial T2 FLAIR MRI, obtained
2 years after the initial scan, confirmed the presence of white matter lesions, judged to be
consistent with McDonald criteria  (See Figure 2). Due to a lack of progression, these lesions
are  considered  stable  and  this  participant  has  remained  free  of  clinical  symptoms.  This
participant  had  more  than  20 identified  lesions  in  periventricular  and juxtacortical  white
matter. Periventricular lesions were in frontal and parietal areas, while juxtacortical lesions
were distributed across frontal, parietal and temporal regions. This subject was scanned for
Hubbard et al., unpublished data (see Table 2).
Subject 3 (Edinburgh, UK) participated in synaesthesia research in 2008 and her resultant
axial  T2  MRI  scan  was  also  examined  routinely  by  a  consultant  radiologist  to  detect
unanticipated  pathology.  Initial  examination  revealed  white  matter  hyperintensities  in  the
brain of this subject. This T2-weighted MRI scan was independently examined by a second
neuroradiologist who confirmed that the number and location of the white matter lesions met
the McDonald imaging criteria for diagnosis of MS (see Figure 3). Again, this participant has
remained free of clinical symptoms since the initial presentation of her abnormal scan. This
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participant had more than 20 lesions in periventricular and juxtacortical white matter (see
Figure 3). Periventricular lesions were found in frontal, parietal, temporal and occipital areas.
Juxtracortical  lesions  were identified in temporal  and parietal  areas.  Infratentorial  lesions
were also present. This subject was scanned for, and subsequently excluded from, a study by
Simner et al., in review (see Table 2).
-----------------------------------------
Insert figures 1-3 here
-----------------------------------------
Case-details of all synaesthetes with existing MRI scans
Table 2 shows what is to our knowledge all studies that have generated MRI scans from
synaesthete participants at the time of writing including all published studies, plus our two
unpublished samples. Published articles were retrieved from an all-years search of PubMed
using search terms “syn*esthesia” (UK/US spellings) and “MRI”, and any additional details
on participants shown below that were not available in the literature were retrieved by contact
with the authors of these studies. 
Table 2. MRI studies of synaesthete participants. Table shows Year (of publication; or year
of report for unpublished studies), Authors, Total n (total participant numbers), Status with
respect to radiological anomalies (see key; unknown unless otherwise stated), and Female n
(number of female participants).
Year Authors Total n Status Female n
European
studies     
2001 Aleman et al. 1 ¥ 1
2001 Weiss et al. 1 † 1
2005 Weiss et al. 9 † 6
2006 Hubbard et al. (unpublished) 10  10
2006 Sperling et al. 4  4
2007 Rouw & Scholte 0  0
2008 Hanggi et al. 1 ¥ 1
2009 Janke et al. 0  0
2009 Weiss & Fink 16 † 15
2010 Rouw & Scholte 42 ¥ 42
2010 van Leeuwen et al. 21 ¥ 19
2011 Gaschler-Markefski et al. 7 ¥ 6
2011 Hanggi et al. 24 ¥ 20
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2011 Specht & Laeng 2 †† 2
2011 van Leeuwen et al. 0  0
2012 Dovern et al. 5 † 5
2012 Hupe et al. 10 ¥ 7
2012 Neufeld et al. 14 ¥ 9
UK studies     
2002 Nunn et al. 13 †† 13
2005 Blakemore et al. 1 †† 1
2006 Gray et al. 2 †† 2
2007 Cohen Kadosh et al. 1 †† 0
2008 Bor et al. 1 †† 0
2008 Tang et al. 10 †† 8
2011 Jones et al. 2 †† α 1
2012 Banissy et al 9 † 5
2013 Simner et al. (in review) 13  13
N. American
studies     
2003 Elias et al. 1 ¥ 1
2005 Hubbard et al. 6  3
2012 Brogaard et al. 1 †† 0
Other studies     
2006 Rich et al. 7 †† 6
 TOTAL 234  201
Key
* Subject numbers have been adjusted to exclude duplicate participants already scanned in previous studies by
the same group (shown elsewhere in the table)
 Members of our study cohort (i.e., studies directed in our labs); 3 anomalies in n=29 scans
α A study directed by colleagues outside our labs but JS co-authoring
† Routine radiological checks for pathology performed by neurologist and no anomalies found 
†† Routine radiological checks carried out by a neuroradiologist and no anomalies found
¥ No routine radiological checks for pathology performed
Analysis of the prevalence of MS-RIS cases among scanned synaesthetes against expected
baselines.
We have found three cases of MS-RIS in 234 synaesthetes who have self-referred for brain
scanning studies across the literature. In order to establish whether the number of affected
synaesthetes is statistically significant, we must compare the prevalence of observed cases
against a meaningful baseline. Since RIS and MS are indistinguishable, from a radiological
perspective, we first consider all three cases as a unified phenomenon. Then, since RIS and
MS are different in a clinical/symptomatic sense, we additionally consider the two cases of
RIS as a distinct phenomenon. Methodologically speaking, we will take our RIS baseline
from a meta-analysis of the prevalence of RIS across all MRI scans described in the imaging
literature (and below we describe our very conservative approach in this regard). We will take
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our MS baselines from rates reported in clinical prevalence studies. Since the prevalence of
MS is sex-linked and geographically variable, we have considered that the large majority of
all scanned synaesthetes are female (86%) and have come from studies conducted in Europe
(94%). Accordingly,  we took a female MS prevalence figure for Europe.  Again however,
since a key aim was to be maximally conservative (i.e., to compare our findings with the
highest prevalence rates where possible), we additionally re-analysed our data using the most
stringent  prevalence  rate  according  to  the  nationality  of  the  three  affected  cases
(American/French/English). In other words, since the rate of MS is highest in England (vs.
America or France), we used this highest England baseline in a second analysis. Below we
describe  these  baseline-selection  procedures  in  more  detail,  and  the  resultant  statistical
outcomes of our analyses (showing whether MS-RIS is indeed significantly higher in self-
referred synaesthete samples).
Baseline selection, and results: There is no published combined prevalence of MS-RIS, so
we use an additive value from each separately. Our recent meta-analysis (Morris et al., 2009)
shows a baseline of RIS in the general population of 57.8/100,000. This figure was based on
nine cases of unanticipated WMH considered as definite demyelination, which were found in
15,559 scans reported in the literature. To be conservative here, we will also include three
cases  of  possible demyelination  in  that  meta-analysis,  and furthermore,  we will  consider
scans only from self-referred volunteer research participants (giving a total of 12 RIS cases
found in 8,441 research scans; Proportion (P) =0.14%, 95% CI [0.08%, 0.25%]; Morris et al.,
2009). We consider only self-referred volunteers because this type of participant is similar to
those  in  our  own cohort  of  synaesthetes,  and across  the  234 scanned  synaesthetes  more
widely. It is important to consider this method of (self-) referral since it may have elevated
the number of RIS cases in our cohort. Specifically, self-referred/volunteer recruitment in any
brain imaging study may increase rates of neuropathology by over-recruitment of participants
who are  seeking covert  evaluation  for  undeclared  neurological  complaints  (Morris  et  al.,
2009). In other words, our three affected synaesthetes may have volunteered for our studies in
order  to  assuage  personal  neurological  concerns,  and  we  must  therefore  compare  their
number against  a baseline that  specifically takes this  into account.  In summary,  all  these
considerations  give  us  a  comparative  baseline  for  RIS  in  the  general  population  of
142/100,000. However, we point out that this baseline is likely to be highly inflated since
closer inspection of the data that contributed to our meta-analysis reveals that two-thirds of
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cases contributing to this figure were found in a single study in which 90.0% of participants
were former lead workers with a mean age of 60.1 years (Alphs et  al.,  2006).  Since the
likelihood of detecting WMH increases significantly with age (Smith et al., 2000) and with
exposure to neurotoxicants such as lead (Stewart et al., 2006), the true prevalence of WMH in
the general population of self-referred volunteers is likely to be substantially lower than the
baseline we are selecting here. Nonetheless, we use this baseline as a maximally conservative
estimate (to combine with a suitable estimate for MS prevalence below), for comparison with
our synaesthete sample. 
The prevalence of MS in the general population is better understood, and known to vary by
geographic region (with particularly high rates in Scotland (Sutherland, 1956) and by sex:
females approximately 2:1; Pugliatti et al., 2006). This is of note given our Edinburgh testing
study (in which four of 13 participants were Scottish; the remainder travelled from England)
and the fact that the scanned synaesthesia population is skewed towards females (F= 201) --
as potentially, is synaesthesia in general (e.g., see Ward and Simner, 2005). Considering the
sex and nationality of the 234 scanned synaesthetes (using the location of testing centres as
an indicator of nationality for cases unknown to us), an appropriate baseline is the rate of MS
in female Europeans (110/100,0002) since synaesthetes were virtually exclusively European
(94%, n=220; including four Scots, none of whom showed pathology). This we combined
with the baseline for RIS to give an additive RIS-MS baseline of 252/100,000. 
Using the exact binomial test, we calculated the probability of obtaining our observed number
of  MS-RIS  cases  within  scanned  synaesthetes,  given  the  expected  baseline  prevalence
estimates generated above.  Thus, we estimated the probability of three observations of MS-
RIS among 234 self-referred synaesthetes (Proportion (P) =1.3%, 95% binomial CI [0.3%,
3.7%];  1282/100,000)  given  an  expected  population  prevalence  of  252/100,000.  Our
statistical  test  shows this  rate  among synaesthetes  to  be significantly higher  than  chance
might predict (p=.02). This difference remains significant (p=.04) even if we substitute the
female Europe MS rate and use instead the female England MS rate3, as the most extremely
2 Calculation of the rate of female MS in Europeans: Pugliatti et al. (2006) report that “the total 
estimated prevalence rate of MS [in Europe] for the past three decades is 83 per 100 000 with … a 
female: male ratio around 2.0” (p. 700). On this basis, and given the overall population sex ratio in 
the European Union (0.96 males to each female; The World Factbook 2011. Washington, DC: Central 
Intelligence Agency, 2011) we calculate the estimated European female MS rate at 110/100,000.
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conservative  option  given  the  demographics  of  our  three  affected  cases
(American/French/English). 
Combining our three cases has allowed us to consider the shared MRI profile of MS and RIS,
and their related clinical progression (Granberg et al., 2013). However, we might alternatively
exclude our case of MS as a separate phenomenon, and consider only our two observations of
RIS against all 103 scans with protocols to check for such anomaly (P=1.9%, 95% binomial
CI [0.2%, 6.7%]. Taking again our highest RIS baseline (142/100,000), this finding is also
highly significant (p=.01). Indeed, taking even the most extreme assumption of no other cases
in any synaesthete scanned to date – checked or unchecked -- an observation of two cases in
234 (P=0.9%; binomial CI [0.1%, 3.1%]) remains significant (p=.04)4. 
Discussion
We initially observed three cases showing white-matter hyperintensities compatible with the
radiological profile of MS -- one case of MS and two of RIS -- in 29 synaesthetes from three
of our imaging labs across three different countries. We have taken the most conservative
approach  in  assuming  no  further  cases  in  any synaesthetes  scanned  to  date,  placing  the
prevalence  at  three  affected  cases  in  234  synaesthetes  (1,282/100,000,  compared  to  a
population baseline estimate of 252/100,000). Two cases of RIS in 103 brain scans checked
for  pathologies  would,  if  representative,  place  the  prevalence  of  RIS  in  synaesthetes  at
1,942/100,000 (compared to a baseline of 142/100,000). These rates are significantly higher
3 Calculation of the rate of female MS in England: There was no available data for female MS 
prevalence in England per se, and so we calculated this based on the rate of MS in eastern England 
(153/100,000; the highest regional rate in England reported by Compston et al., 2006) and the male: 
female ratio of MS (2:1; Compston et al., 2006) in combination with the overall population 
prevalence of women versus men in the United Kingdom (1.01:1; The World Factbook 2011. 
Washington, DC: Central Intelligence Agency, 2011). This gives an estimate of female MS in England 
at 204/100,000.
4  Analysing the RIS cases and MS case separately serves an additional purpose. The MS case was the 
first reported case, and as such, can be viewed as the observation that led to the forming of our 
hypothesis. It could be argued that including this case in subsequent analyses, especially given the 
small numbers of cases involved, may lead to inappropriate conclusions being drawn. It is important 
to point out therefore that when this initial case is excluded and the subsequent two cases are 
analysed, the outcome remains statistically significant, adding further methodological rigour for this 
hypothesis.
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than  expectation,  even  against  our  highly  conservative  baselines.  We  also  specifically
controlled  for  the  possibility that  our  three  affected  cases  may have  volunteered  for  our
studies in order to assuage personal neurological concerns. We did this by comparing our RIS
cases  to  a  baseline  constructed  only  from  studies  that  included  similar,  self-referred,
volunteer participants. In other words, we compared our rates to studies likely to have just as
many  ‘concerned  self-referrers’ as  our  own,  rather  than  to  studies  using  non-voluntary
recruitment methods (e.g., work-related health screening; Weber and Kopf, 2004). 
We would like to very clearly acknowledge that we report only a small number of affected
cases, and we evidently do not claim that synaesthesia causes MS-RIS. Indeed, our small
sample  size  means  we hold  back from making any strong claim whatsoever  about  links
between these two conditions. There are many environmental factors thought to contribute to
the development of MS and RIS; the evidence we present here suggests having synaesthesia
may be one factor that could merit further investigation. Indeed, we have chosen to present
our data for two reasons. The first is that the rates we have found are statistically significant;
a considerably greater sample size would usually be needed in order to detect the numbers we
have found – although again our sample sizes are small. The second reason we present our
data is a practical one: cases of pathology are usually excluded from MRI study populations
as soon as they are detected.  Therefore, they often do not appear in the literature and so
remain unknown outside the research group. We have published our data because we judge it
important that other researchers working in this area are aware of our cases, and so might not
overlook future neurological abnormalities, should they ever be discovered. If a meaningful
link between synaesthesia and MS did exist,  and as scanning of synaesthetes for research
purposes becomes more commonplace, further cases of this nature would arise, and so we
encourage  researchers  to  make  any cases  known  to  the  wider  community  if  they  share
similarities with our own. 
One  explanation  for  a  link  between  synaesthesia  and  MS  could  be  the  occurrence  of
synaesthesia-like symptoms  after the onset of MS. In other words,  it  is  possible that the
degenerative neurological damage caused by MS might give rise to sensory disorders that
mimic synaesthesia, while having different causes. Sensory disturbances do accompany MS
(e.g., changes in colour vision; Gregori et al., 2011) although this hypothesis would imply
that the onset of synaesthesia-like symptoms should be later in life -- resulting from MS-
related changes in brain structure. However, we do not believe this accounts for the cases we
present here, and for two reasons. Later-acquired synaesthesias are qualitatively different to
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developmental variants (Ward, 2013) and do not reflect the synaesthesias of our participants.
Acquired  variants  of  synaesthesia  tend to  involve  low-level  sensory triggers  (e.g.,  tones)
rather than learned symbols such as graphemes (Ward, 2013) although it  is precisely this
latter type of trigger (graphemes etc.) that our own cases possess – and which might therefore
be considered a hallmark of developmental synaesthesia. Furthermore, all three of our cases
report life-long synaesthesia, stemming back from early childhood, and being present for as
long as they can remember. 
Finally, we point out one recent finding that might be considered alongside our own. Bashir,
Lipton, Ashina and Ashina (2013) have shown white matter abnormalities in people suffering
migraine, especially those for whom the migraine is accompanied by auras. Migraine has
been  linked  with  synaesthesia  (e.g.,  Alstadhaug  &  Benjaminsen,  2010)  and  the  auras
associated with migraine are visual disturbances which themselves might be considered as
resembling certain types of synaesthetic sensations (e.g., coloured photisms). Future studies
might therefore further explore any possible links between synaesthesia and migraine and the
types of visual disturbances they each engender. 
In conclusion to the current study, we have demonstrated an apparent statistical link between
MS-RIS and synaesthesia. Overall, we have been conservative in our study in three ways: we
selected  baselines  in  an  overly  conservative  way;  we  took  additional  measures  to  be
conservative when conducting our statistical analysis (e.g., assuming no anomalies in scans
not assessed by radiologists); and we are circumspect in the interpretation of our findings.
Because our study relies on a small number of cases – three only -- we do not claim that any
causal link exists between synaesthesia and MS-RIS, and we present our findings with this
strong caveat.  Nonetheless,  we present  these significant  data  so that  imaging researchers
might consider them when evaluating any anomalies that may arise in future studies. If our
epidemiological findings are indeed later supported by additional evidence, this could invite a
debate about the clinical status of synaesthesia, which has previously been associated with
largely beneficial rather than unfavourable characteristics (but see Carruthers et al., 2012). In
order  to  investigate  this  hypothesis  further,  we  are  currently  also  exploring  whether
developmental synaesthesia is found in high numbers within populations of people with MS,
which would enable firmer conclusions to be drawn regarding the validity or otherwise of the
statistical associations we report here. 
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Figures 
Figure 1. Axial T2-weighted image showing a left parietal ovoid periventricular lesion (of 16
overall lesions), from Subject 1
Figure 2. Axial T2-weighted FLAIR images showing (left) a left frontal periventricular lesion
and (right) multiple lesions; the right parietal lesion involves juxtacortical U fibres
Figure  3.  Axial  T2-weighted  image  showing  multiple  ovoid  periventricular  white  matter
lesions, from Subject 3
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